CXCL8 and obesity due to melanocortin 4 receptor deficiency: The increased production of propionate would have implications for the treatment of obesity and related metabolic and immune alterations, as propionate administration has been shown to induce satiety [79], improve glucose homeostasis [80, 81], and suppress proinflammatory interleukin-8 levels [80] in humans.